Granules India, a pharmaceutical company headquartered in Hyderabad, has partnered with Greenko Group to create the first-ever Integrated Green Pharmaceutical Zones (GPZ) located in Kakinada, Andhra Pradesh.
Through this, Granules India aims to establish a leadership position in sustainability and circular economy initiatives and be a pioneer in the sector through its strategic partnership with Geenko ZeroC to collaborate for Green Molecule Solutions and its more comprehensive applications in pharmaceuticals. This is crucial since bulk medication manufacturers are considered a dirty business, and the pharmaceutical industry frequently uses chemicals connected to high carbon emissions.
One of the world’s biggest producers of metformin and paracetamol is granules. To manufacture essential starting materials (KSM), intermediates, active pharmaceutical ingredients (APIs), and fermentation-based products on a big scale, Granules will construct a green field facility based on sustainability principles. A phased approach will be taken to commission the 100-acre complex. According to the release, the project is expected to cost around Rs 2,000 crore over five years. Granules will be made with carbon-free energy and green hydrogen derivatives from Greenko ZeroC, which are also utilized to create KSMs for paracetamol and anti-diabetic drugs.
A step-down subsidiary of the parent company Greenko Energy Holdings (GEH), Greenko Zero C, was created for several green hydrogen and energy transition initiatives. According to the corporation, the partnership enables the use of fungible carbon offset instruments throughout Granules’ international manufacturing facilities.
According to a business release, Greenko ZeroC would provide carbon-free energy and enable the production of green hydrogen and its many chemical derivatives. At this facility, Granules will also produce products based on fermentation that require a lot of energy.
